Importantly, breast cancer therapies depend on the stage and subtype of the tumor and range from surgical interventions, radio- and chemotherapy, to targeted therapies that specifically inhibit molecular features such as ER and HER2 expression. This evidence concerns the gene ESR1 and breast cancer.